Download PDF
Thromb Haemost 1994; 72(01): 125-131
DOI: 10.1055/s-0038-1648823
Original Article
Schattauer GmbH Stuttgart

Platelet Thrombospondin Interactions with Human High and Low Molecular Weight Kininogens

Raul A DeLa Cadena
1   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
4   Departments of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA, USA
,
Edward G Wyshock
1   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
2   Departments of Medicine, Temple University School of Medicine, Philadelphia, PA, USA
,
Satya P Kunapuli
1   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
3   Departments of Physiology, Temple University School of Medicine, Philadelphia, PA, USA
,
Robert L Schultze
1   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
,
Michelle Miller
4   Departments of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA, USA
,
Daniel A Walz
5   Department of Physiology, Wayne State University School of Medicine, Detroit, Ml, USA
,
Robert W Colman
1   The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA
2   Departments of Medicine, Temple University School of Medicine, Philadelphia, PA, USA
3   Departments of Physiology, Temple University School of Medicine, Philadelphia, PA, USA
› Author Affiliations
Further Information

Publication History

Received 27 August 1993

Accepted after resubmission 16 March 1994

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Multifunctional proteins, e.g. high molecular weight kininogen (HK, 120 kDa) and the homotrimer, thrombospondin (TSP, 540 kDa), which have more than one domain on a single polypeptide chain, are particularly well-suited to be structural elements of extracellular matrices because of their ability to bind to several macromolecules. We now demonstrate that 125I-high molecular weight kininogen (HKa) cleaved by purified kallikrein forms a complex with purified intact platelet TSP (540 kDa). HK also complexed with a proteolytic fragment (450 kDa) of TSP, lacking its three identical heparin-binding domains (HBD, 30 kDa), but failed to bind to a more extensively proteolysed molecule (210 kDa) lacking the C-terminal globular domain indicating that the binding on TSP-450 kDa is confined to the C-terminus. The binding of HK to intact TSP and to its 450 kDa fragment was of high affinity (Kd = 17-52 nM), specific, concentration dependent and saturable. Furthermore, we found both forms of the light chain (LC) of HK (56 and 46 kDa) resulting from cleavage by plasma kallikrein bound to both intact TSP and HBD independent of the presence of calcium ions. However, neither the epitope recognized by monoclonal antibody (MAb) Cl 1C1 on domain 5 nor the prekallikrein binding site on domain 6 are involved, suggesting that the intervening proline-rich region may be the site of interaction. The heavy chain (HC) of HK required ionized calcium to bind to intact TSP or its 450 kDa homotrimer fragment. Purified immobilized low molecular weight kininogen (LK) which contains the identical HC as HK but a different LC was recognized by intact TSP but only in the presence of calcium ions. Since MAb 2B5 inhibited the interaction, domain 2 and/or domain 3 of the HC contains the binding site for TSP. The TSP-HK interaction may play a role in the platelet function since both glycoproteins are present within the a-granules of platelets.

 

  • References

  • 1 Greengard JS, Griffin JH. Receptors for high molecular weight kininogen on stimulated washed human platelets. Biochemistry 1984; 23: 6863-6869
    CrossrefPubMedGoogle Scholar
  • 2 Gustafson EJ, Schutsky D, Knight LC, Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 1986; 78: 310-318
    CrossrefPubMedGoogle Scholar
  • 3 Iwaarden FV, de Groot PG, Bouma BN. The binding of high molecular weight kininogen to cultured human endothelial cells. J Biol Chem 1988; 263: 4693-4703
    PubMedGoogle Scholar
  • 4 Gustafson EJ, Schmaier AH, Wachtfogel YT, Kaufman N, Kucich U, Colman RW. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 1989; 84: 28-35
    CrossrefPubMedGoogle Scholar
  • 5 Higashiyama S, Ohkubo I, Ishiguro H, Sasaki M. Heavy chain of human high molecular weight and low molecular weight kininogens bind calcium ion. Biochemistry 1987; 26: 7450-7458
    CrossrefPubMedGoogle Scholar
  • 6 DeLa CadenaRA, Colman RW. The sequence HGLGHGHEQQHGLG-HGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. Protein Sci 1991; 1: 151-160
    PubMedGoogle Scholar
  • 7 Tait JF, Fugikawa K. Primary structure requirements for the binding of human high molecular weight kininogen to plasma kallikrein and factor XI. J Biol Chem 1987; 262: 11651-11657
    PubMedGoogle Scholar
  • 8 Takagaki Y, Kitamura N, Nakanishi S. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight pre-kininogens. J Biol Chem 1985; 260: 8601-8609
    PubMedGoogle Scholar
  • 9 Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight kininogen glycoprotein from human blood platelets. J Biol Chem 1987; 283: 8609-8616
    PubMedGoogle Scholar
  • 10 Benzinger NL, Brodie GN, Majerus PW. Isolation and properties of a thrombin sensitive protein of human platelets. Proc Natl Acad Sci USA 1971; 68: 240-243
    CrossrefPubMedGoogle Scholar
  • 11 Galvin NJ, Dixit VM, O’Rourke KM, Santoro SA, Grant GA, Frazier WA. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J Cell Biol 1985; 101: 1434-1441
    CrossrefPubMedGoogle Scholar
  • 12 Dixit VM, Hennessy SW, Grant GA, Rotwein P, Frazier WA. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. Proc Natl Acad Sci USA 1986; 83: 5449-5453
    CrossrefPubMedGoogle Scholar
  • 13 Lawler J, Derick LH, Connolly JE, Chen J-H, Chao F. The structure of human platelet thrombospondin. J Biol Chem 1985; 260: 3762-3772
    PubMedGoogle Scholar
  • 14 Lahav J, Lawler J, Gimbrone MA. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding. Eur J Biochem 1984; 145: 151-156
    PubMedGoogle Scholar
  • 15 Bacon-Baguley T, Ogilvie ML, Gartner TK, Walz DA. Thrombospondin binding to specific sequences within the Aa- and Bp-chains of fibrinogen. J Biol Chem 1990; 265: 2317-2323
    PubMedGoogle Scholar
  • 16 Silverstein RL, Leung LL, Harpel PC, Nachman RL. Complex formation of platelet thrombospondin with plasminogen. J Clin Invest 1984; 74: 1625-1633
    CrossrefPubMedGoogle Scholar
  • 18 Lawler J, Simons E. Cooperative binding of calcium and limited tryptic digestion of thrombospondin with plasminogen. J Clin Invest 1983; 258: 12098-12101
    PubMedGoogle Scholar
  • 19 Long MW, Dixit VM. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. Blood 1990; 75: 2311-2318
    PubMedGoogle Scholar
  • 20 Tuszynski GP, Rothman VL, Murphy A, Siegler K, Knudsen KA. Thrombospondin promotes platelet aggregation. Blood 1988; 72: 109-115
    PubMedGoogle Scholar
  • 21 Bale MD, Westrick LG, Mosher DF. Incorporation of thrombospondin into fibrin clots. J Biol Chem 1985; 260: 7502-7508
    PubMedGoogle Scholar
  • 22 Mansfield PJ, Dixit VM, Boxer LA, Suchard SJ. Thrombospondin stimulates chemotaxis and chemokinesis in human neutrophils. J Cell Biol 1989; 109: 112a (abstract)
    PubMedGoogle Scholar
  • 23 McClaren KM. Immunochemical localization of thrombospondin on human megakaryocytes and platelets. J Clin Pathol 1983; 36: 197-199
    CrossrefPubMedGoogle Scholar
  • 24 Kerbiriou DM, Griffin JH. Human high molecular weight kininogen studies on structure-function relationship and of proteolysis of the molecule occurring during contact activation of plasma. J Biol Chem 1979; 254: 12020-12027
    PubMedGoogle Scholar
  • 25 Proctor RR, Rapaport SJ. The partial thromboplastin time with kaolin: the simple screening test of the first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 212-219
    CrossrefPubMedGoogle Scholar
  • 26 Scott CF, Liu CY, Colman RW. Human plasma prekallikrein. A rapid high yield method for purification. Eur J Biochem 1979; 100: 77-83
    PubMedGoogle Scholar
  • 27 Bacon-Baguley T, Kudrik BJ, Walz DA. Thrombospondin interaction with fibrinogen. J Biol Chem 1987; 262: 1927-1930
    PubMedGoogle Scholar
  • 28 Fraker PC, Speck Jr SC. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3a6a-diphenyl-glycouril. Biochem Biophys Res Commun 1978; 80: 849-857
    CrossrefPubMedGoogle Scholar
  • 29 Laemmli UK. Cleavage of the structural proteins during assembly of the head of the bacteriophage T4. Nature (London) 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 30 Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. Measurement of the five affinity constants in solution of antigen-antibody complexes by enzyme-linked immunoabsorbent assay. J Immunol Methods 1985; 77: 305-319
    CrossrefPubMedGoogle Scholar
  • 31 Schmaier AG, Schutsky D, Farber A, Silver LD, Bradford HN, Colman RW. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies decreased to each of its chains. J Biol Chem 1987; 262: 1405-1411
    PubMedGoogle Scholar
  • 32 DeLa Cadena RA, Bradford HN, Kunapuli SP, Colman RW. The platelet binding site on the heavy chains of human high (HK) and low (LK) molecular weight kininogens is confined to residues Lys-262-Pro-272. Thromb Haemost 1993; 69: 781a
    PubMedGoogle Scholar
  • 33 Dixit VM, Galvin NS, O’Rourke KM, Frazier WA. Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin: characterization and mapping of their epitopes. J Biol Chem 1987; 261: 1962-1968
    PubMedGoogle Scholar
  • 34 Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into the extracellular matrix. Proc Natl Acad Sci USA 1983; 80: 998-1002
    CrossrefPubMedGoogle Scholar
  • 35 Danishefsky KJ, Alexander RJ, Detweiler TC. Formation of a stable complex of thrombin and the secreted platelet glycoprotein C (thrombin-sensitive protein thrombospondin) by thiol-disulfide exchange. Biochemistry 1984; 23: 4984-4990
    CrossrefPubMedGoogle Scholar
  • 36 Puri RN, Zhou F-X, Hu C-J, Colman RF, Colman RW. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Blood 1991; 77: 500-507
    PubMedGoogle Scholar
  • 37 Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem 1991; 266: 6786-6794
    PubMedGoogle Scholar
  • 38 Jiang YP, Muller-Esterl W, Schmaier AH. Domain 3 of kininogens contains a cell-binding site and a site that modified thrombin activation of platelets. J Biol Chem 1992; 267: 3712-3717
    PubMedGoogle Scholar
  • 39 Weisel JW, Negaswami C, Woodhead JL, DeLa Cadena RA, Page JD, Colman RW. The shape of high molecular weight kininogen: organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem 1994; 269: 10100-10106
    PubMedGoogle Scholar
  • 40 Frazier WA. Thrombospondin: A modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 1987; 105: 625-632
    CrossrefPubMedGoogle Scholar